188 related articles for article (PubMed ID: 33767937)
1. Hydroxyurea Use Among Children With Sickle Cell Disease at King Abdulaziz University Hospital in Jeddah City.
Alzahrani F; Albaz GF; AlSinan F; Alzuhayri J; Barnawi ZM; Melebari N; Al Twairgi TM
Cureus; 2021 Feb; 13(2):e13453. PubMed ID: 33767937
[TBL] [Abstract][Full Text] [Related]
2. The role of hydroxyurea in decreasing the occurrence of vasso-occulusive crisis in pediatric patients with sickle cell disease at King Saud Medical City in Riyadh, Saudi Arabia.
Azmet FR; Al-Kasim F; Alashram WM; Siddique K
Saudi Med J; 2020 Jan; 41(1):46-52. PubMed ID: 31915794
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Cholelithiasis Among Patients With Sickle Cell Disease: A Tertiary Care Center Experience.
Almalki B; Banser S; Alghamdi B; Almalki M; Al-Marzouki A; Alharthi M; Radhwi O
Cureus; 2023 Mar; 15(3):e36761. PubMed ID: 37123707
[TBL] [Abstract][Full Text] [Related]
4. Impact of Hydroxyurea Therapy in Reducing Pain Crises, Hospital Admissions, and Length of Stay Among Sickle Cell Patients in the Eastern Region of Saudi Arabia.
Albohassan H; Ammen M; Alomran AA; Bu Shehab H; Al Sakkak H; Al Bohassan A
Cureus; 2022 Nov; 14(11):e31527. PubMed ID: 36540486
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Laboratory Features of Sickle Cell Disease S/D Punjab: Impact of HbF and Hydroxyurea.
Alkindi S; Al-Busaidi IBM; Pathare AV
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024046. PubMed ID: 38882454
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Causes of Hospitalization Among Children with Sickle Cell Disease in a Group of Private Hospitals in Jeddah, Saudi Arabia.
Abd El-Ghany SM; Tabbakh AT; Nur KI; Abdelrahman RY; Etarji SM; Almuzaini BY
J Blood Med; 2021; 12():733-740. PubMed ID: 34408522
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Depression and Anxiety Among Sickle Cell Disease Patients in King Abdulaziz University Hospital.
Al-Marzouki AF; Alrefaie NI; Aljohani NA; Alandanusi RA; Alghamdi AA; Radhwi OO
Cureus; 2021 Sep; 13(9):e18374. PubMed ID: 34646713
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Painful Crisis and Other Associated Complications of Sickle Cell Anemia Among Children.
Sendy JS; Alsadun MS; Alamer SS; Alazzam SM; Alqurashi MM; Almudaibigh AH
Cureus; 2023 Nov; 15(11):e48115. PubMed ID: 38046719
[TBL] [Abstract][Full Text] [Related]
9. Renal outcomes in pediatric patients with sickle cell disease: a single center experience in Saudi Arabia.
Monagel DA; Algahtani SS; Karawagh LA; Althubaity WD; Azab SA; Haneef DF; Elimam N
Front Pediatr; 2023; 11():1295883. PubMed ID: 38161437
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Laboratory Predictors of Painful Vaso-Occlusive Crisis Among Sickle Cell Disease Patients: A Single-Center Study in Saudi Arabia.
Zakaria O; Buhalim RA; Almulhim F; Al Jabr FA; Alrashid A; Almutairi M
Cureus; 2021 May; 13(5):e14980. PubMed ID: 34123674
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea therapy in children severely affected with sickle cell disease.
Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and Complications Among Pediatric Patients With Sickle Cell Anemia: A Single Tertiary Center Retrospective Study.
Alzahrani F; Fallatah AM; Al-Haddad FM; Khayyat ST; AlMehmadi WM; AlQahtani BG; Alamri RS
Cureus; 2021 Jan; 13(1):e12440. PubMed ID: 33552759
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
14. Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report.
Kvam AK; Torp HA; Iversen PO
Cureus; 2021 Dec; 13(12):e20236. PubMed ID: 35004051
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of bacterial infections in febrile children with sickle cell disease.
Alzahrani F; Alaidarous K; Alqarni S; Alharbi S
Int J Pediatr Adolesc Med; 2021 Dec; 8(4):236-238. PubMed ID: 34401448
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
Tavakkoli F; Nahavandi M; Wyche MQ; Castro O
Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective.
Sharef SW; Al-Hajri M; Beshlawi I; Al-Shahrabally A; Elshinawy M; Zachariah M; Mevada ST; Bashir W; Rawas A; Taqi A; Al-Lamki Z; Wali Y
Eur J Haematol; 2013 Jun; 90(6):519-24. PubMed ID: 23489171
[TBL] [Abstract][Full Text] [Related]
18. Higher oxygen saturation with hydroxyurea in paediatric sickle cell disease.
van Geyzel L; Arigliani M; Inusa B; Singh B; Kozlowska W; Chakravorty S; Bossley CJ; Ruiz G; Rees D; Gupta A
Arch Dis Child; 2020 Jun; 105(6):575-579. PubMed ID: 31871045
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
Al-Jam'a AH; Al-Dabbous IA
Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
[TBL] [Abstract][Full Text] [Related]
20. The Prevalence of Cardiovascular Manifestations in Pediatric Sickle Cell Anemia Patients in a Large Tertiary Care Hospital in the Western Region of Saudi Arabia.
Waggass R; Alhindi AK; Bagabas IS; Alsaegh MH; Alsharef NK; Morya RE; Khan MA; Jastaniah W
Cureus; 2023 Mar; 15(3):e35751. PubMed ID: 37020484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
